These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36796014)

  • 1. Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review.
    Perez VL; Mah FS; Willcox M; Pflugfelder S
    J Ocul Pharmacol Ther; 2023 Mar; 39(2):89-101. PubMed ID: 36796014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for dry eye disease.
    Mason L; Jafri S; Dortonne I; Sheppard JD
    Expert Opin Emerg Drugs; 2021 Dec; 26(4):401-413. PubMed ID: 34846978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Topics in Dry Eye Disease.
    Chiaradia PA; Zeman Bardeci LA; Dankert S; Mendaro MO; Grzybowski A
    Curr Pharm Des; 2017; 23(4):608-623. PubMed ID: 27928967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
    Xia Y; Zhang Y; Du Y; Wang Z; Cheng L; Du Z
    J Nanobiotechnology; 2024 May; 22(1):233. PubMed ID: 38725011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
    Zhuang D; Misra SL; Mugisho OO; Rupenthal ID; Craig JP
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.
    Reyes JL; Vannan DT; Eksteen B; Avelar IJ; Rodríguez T; González MI; Mendoza AV
    Mediators Inflamm; 2018; 2018():2532314. PubMed ID: 30158831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Video display terminal use and dry eye: preventive measures and future perspectives.
    Kamøy B; Magno M; Nøland ST; Moe MC; Petrovski G; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Nov; 100(7):723-739. PubMed ID: 35122403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology, diagnosis, and treatment of dry eye disease.
    Messmer EM
    Dtsch Arztebl Int; 2015 Jan; 112(5):71-81; quiz 82. PubMed ID: 25686388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The core mechanism of dry eye disease is inflammation.
    Wei Y; Asbell PA
    Eye Contact Lens; 2014 Jul; 40(4):248-56. PubMed ID: 25390549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intricate insights into immune response in dry eye disease.
    Kaur RP; Gurnani B; Kaur K
    Indian J Ophthalmol; 2023 Apr; 71(4):1248-1255. PubMed ID: 37026255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsanthin from Capsicum annum fruits exerts anti-glaucoma, antioxidant, anti-inflammatory activity, and corneal pro-inflammatory cytokine gene expression in a benzalkonium chloride-induced rat dry eye model.
    Shanmugham V; Subban R
    J Food Biochem; 2022 Oct; 46(10):e14352. PubMed ID: 35892258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.
    Jeyabalan N; Pillai AM; Khamar P; Shetty R; Mohan RR; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1285-1291. PubMed ID: 37026260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.